TCF7L2 and metabolic dysfunction-associated steatotic liver disease: The functions of Wnt signalling in regulating hepatic glucose metabolism have been reported elsewhere57, and in humans, genetic variants and aberrant methylation profiles of TCF7L2 have been associated with the development of type 2 diabetes58, 59, increased NAFLD and fibrosis60.